GlassScriptPhysician profile
Ran Lador
NPI 1154804649
$24,579.85
in general payments reported to CMS, 2019-2025
19 companies · $7,817 in 2025
The $7,817 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,008 · 2021: $1,784 · 2022: $3,190 · 2023: $7,298 · 2024: $3,483 · 2025: $7,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $7,463 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,135.19 |
| Food and Beverage | $7,463.19 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $10,368.50 | 2020-2025 | Icotec Blackarmor Spine System, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Stryker Corporation | $3,523.09 | 2020-2024 | Yukon Oct Spinal System, N/A, Vitoss |
| Alphatec Spine, INC | $2,796.82 | 2023-2025 | Other - Miscellaneous |
| Medinc of Texas | $2,370.27 | 2024-2025 | |
| Arthrex, INC. | $1,714.61 | 2024-2025 | |
| Si-Bone, INC. | $741.65 | 2021-2025 | |
| Carbofix Spine INC | $601.59 | 2020-2021 | |
| Cerapedics INC. | $402.51 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Highridge Medical LLC | $386.21 | 2025 | Mobi-C Plug & Fit US |
| Providence Medical Technology, INC. | $381.69 | 2025 | |
| Medtronic, INC. | $322.72 | 2024-2025 | Osteocool Rf Ablation System, Unid_pass |
| Ulrich Medical USA, INC. | $185.50 | 2022 | |
| Kuros Biosciences USA, INC | $158.53 | 2023 | |
| Centinel Spine, LLC | $143.51 | 2025 | Prodisc C Vivo |
| Pacira Pharmaceuticals Incorporated | $124.77 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $105.69 | 2022 | |
| Globus Medical, INC. | $100.63 | 2024 | Excelsius Deformity |
| Heron Therapeutics, INC. | $96.34 | 2025 | Zynrelef |
| Implanet America, INC. | $55.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ran Lador listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.